William Guyer, Chief Development Officer at CORCEPT THERAPEUTICS INC (CORT), sold 20,000 shares at $93.11 ($1.9M) on 2026-07-07, disclosed to the SEC on 2026-07-08.
Scheduled sale ($1.9M) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $93.11 | 19,048 | $1.8M | 95.2% |
| 2 | $93.54 | 952 | $89K | 4.8% |
| Total | $93.13 avg | 20,000 | $1.9M | 100% |
| Filing → |
| CORT | SELL | 2026-05-07 | $1.0M | — | Filing → |
| CORT | SELL | 2026-04-08 | $819K | — | Filing → |
| CORT | SELL | 2026-03-24 | $424K | — | Filing → |